Sign In
Buy EDIT
$2.78
-0.0400 (-1.42%)
At Close: Jun 03, 2026
Portfolio Manager Thinks Gene-Editing Stocks Could Outperform Tesla
05:36pm, Friday, 08'th Jan 2021
A leading portfolio manager recently told Bloomberg Television that gene-editing companies may turn out to be better investment opportunities than Tesla Inc. (NASDAQ:TSLA).
Domino's, FedEx, Lockheed, Roku and More of Tuesday Afternoon's Analyst Calls
12:52pm, Thursday, 07'th Jan 2021
Over halfway through the trading day on Thursday, and the broad markets are making a run into the afternoon.
3 Biotech Technological Developments to Watch Out For in 2021
09:47am, Thursday, 07'th Jan 2021
Here we discuss three booming technological developments in the biotech sector, which can capture investor attention in 2021
ARKG: Don't Always Follow The Leader
02:27pm, Wednesday, 06'th Jan 2021
ARKG: Don't Always Follow The Leader
3 Biotech Stocks That Could Double Your Money in 2021
06:23am, Tuesday, 05'th Jan 2021
Clinical trial readouts this year could cause these closely watched biotech stocks to explode overnight.
Editas Medicine to Present at the 39th Annual J.P. Morgan Healthcare Conference
04:05pm, Monday, 04'th Jan 2021
CAMBRIDGE, Mass., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome editing company, today announced that it will present a company overview at the 39th Annual
5 Disruptive Biotech Stocks With Solid Long-Term Potential
10:41am, Monday, 04'th Jan 2021
Here we discuss five biotech stocks - EDIT, VRTX, NTLA, CBAY, MRNS - that could prove to be great investments in the long run.
3 Top Biotech Buyout Candidates in 2021
06:09am, Monday, 04'th Jan 2021
Big drugmakers could be attracted to these smaller players with promising pipelines.
Why CRISPR Therapeutics, Editas Medicine, and Intellia Therapeutics Stocks Are Sinking Today
12:27pm, Tuesday, 29'th Dec 2020
The gene-editing stocks are being pulled down by a broader biotech sell-off.
Top ETF of December & Its Best Stocks
12:03pm, Thursday, 24'th Dec 2020
We have highlighted the best ETF of December and its best performing stocks.
Editas surges 50% as ARK founder Cathie Wood sees genomic stocks driving returns for the next 5 years (EDIT)
03:32pm, Monday, 21'st Dec 2020
Shares of Editas Medicine, a genome editing company that utilizes CRISPR technology, soared as much as 50% to new all-time highs on Monday. There was no official news from the company to explain the m
Editas Medicine: 6 Things for Potential EDIT Stock Investors to Know Today
12:33pm, Monday, 21'st Dec 2020
Editas Medicine (EDIT) stock is soaring higher on Monday with heavy trading despite a lack of recent news from the gene-editing company. The post Editas Medicine: 6 Things for Potential EDIT Stock Inv
Why Editas Medicine Stock Is Skyrocketing Today
12:12pm, Monday, 21'st Dec 2020
Here are some best guesses about the biotech stock's huge jump.
5 Biotech Stocks That More Than Doubled This Year
09:47am, Monday, 21'st Dec 2020
The biotech sector has been in focus through 2020 as companies like Moderna (MRNA) strive hard to develop a vaccine for COVID-19.
Editas Medicine Names Meeta Chatterjee, Ph.D., to Board of Directors
04:05pm, Thursday, 17'th Dec 2020
CAMBRIDGE, Mass., Dec. 17, 2020 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ: EDIT), a leading genome editing company, today announced that it has appointed Meeta Chatterjee, Ph.D., to its Board
